{"id":"W2004891108","doi":"10.1007/s00280-012-1843-9","title":"A phase II study of capecitabine, irinotecan, and bevacizumab in patients with previously untreated metastatic colorectal cancer","year":2012,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Occupational Cancer Research Centre; BC Cancer Agency","funders":"","keywords":"Irinotecan; Capecitabine; Medicine; Bevacizumab; Internal medicine; Neutropenia; Clinical endpoint; Colorectal cancer; Adverse effect; Phases of clinical research; Gastroenterology; Oncology; Oxaliplatin; Surgery; Chemotherapy; Cancer; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002062056,0.001658351,0.004383388,0.0006459763,0.000728379,0.001111392,0.0008927402,0.00135882,0.00349559],"category_scores_gemma":[0.00168805,0.001105999,0.001980162,0.0007935106,0.001549258,0.001437818,0.0004395474,0.004212862,0.0006676081],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001437758,"about_ca_system_score_gemma":0.002441325,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003153567,"about_ca_topic_score_gemma":0.00848471,"domain_scores_codex":[0.9991177,0.0004625242,0.00004108539,0.0001474256,0.00006052099,0.0001707981],"domain_scores_gemma":[0.9984757,0.0003186762,0.0002020962,0.000127478,0.00008289408,0.0007931181],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8965161,0.05292618,0.004456385,0.0003928767,0.001108951,0.0001781478,0.0002134384,0.001017222,0.0116813,0.0001387546,0.0009886003,0.03038208],"study_design_scores_gemma":[0.6449855,0.344026,0.008056203,0.00001714796,0.0004736912,0.0001059492,0.00006204568,0.0004488387,0.0007218927,0.0000723411,0.001006518,0.00002371409],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9948677,0.001935946,0.0002650888,0.0003383557,0.0001345116,0.001103555,0.0003359837,0.00002978032,0.0009891619],"genre_scores_gemma":[0.9911374,0.002371866,0.0009846343,0.0006626712,0.0003129097,0.001446889,0.00105722,0.00002363475,0.002002945],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004383388,"threshold_uncertainty_score":0.01169395,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01766081404963258,"score_gpt":0.3373571068421463,"score_spread":0.3196962927925137,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}